Page last updated: 2024-11-12

pyrazolo(1,5-a)pyrimidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pyrazolo(1,5-a)pyrimidine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11636795
CHEMBL ID3246696
SCHEMBL ID19173
MeSH IDM0519961

Synonyms (26)

Synonym
274-71-5
pyrazolo[1,5-a]pyrimidine
AKOS006302298
FT-0688012
pyrazolo[2,3-a]pyrimidine
PB20510
CHEMBL3246696
SCHEMBL19173
LDIJKUBTLZTFRG-UHFFFAOYSA-N
pyrazolo [1,5-a]pyrimidine
pyrazolo[1,5-a]pyrimidine, 97%
mfcd10699580
DTXSID70469781
J-524082
DS-14183
Q7263418
AMY15757
CS-0044088
A850347
EN300-108497
SY074640
pyrazolo(1,5-a)pyrimidine
1,4,7a-triazaindene
unii-nx2kr7m4a4
nx2kr7m4a4 ,
Z1198279686

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Optimization led to the identification of compound 17, a potent, selective and orally available agent with improved physicochemical and pharmacokinetic properties."( Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties.
Buckmelter, AJ; Dinkel, V; Gloor, SL; Gradl, SN; Grina, J; Hastings, G; Laird, ER; Newhouse, B; Rasor, K; Ren, L; Rudolph, J, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1135131Antianxiety activity in mouse assessed as ataxia, catatonia, and alterations in motor activity and startle reflex at 50 mg/kg, ip after 30 to 120 mins1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates.
AID1135132Antianxiety activity in mouse assessed as ataxia, catatonia, and alterations in motor activity and startle reflex at 100 mg/kg, ip after 30 to 120 mins1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (56)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.79)18.7374
1990's0 (0.00)18.2507
2000's9 (16.07)29.6817
2010's35 (62.50)24.3611
2020's11 (19.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.68 (24.57)
Research Supply Index4.04 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.79%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other55 (98.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]